Article Correctness Is Author's Responsibility: Depression: Esketamine trial leaves ‘more questions than answers’

The article below may contain offensive and/or incorrect content.

A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?